Armata Pharmaceuticals Inc.

(ARMP)

By |

Profile

Armata Pharmaceuticals Inc is a clinical-stage biotechnology company focused on improving human health through the development of novel natural and synthetic bacteriophage-based therapies to treat multidrug-resistant bacterial infections and preventable infectious diseases of the microbiome. Its product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains.

Contact Information

Website: www.armatapharma.com
Email: ir@armatapharma.com
Main Phone: +1 858 829-0829
Address: 4503 Glencoe Avenue
Address 2: Suite 100
State: CA
City / Town: Marina del Rey
Country: US
Postal Code: 90292

Issuer Information

Exchange: AMX
CEO: Todd R. Patrick
Employees: 38
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

Profile

Armata Pharmaceuticals Inc is a clinical-stage biotechnology company focused on improving human health through the development of novel natural and synthetic bacteriophage-based therapies to treat multidrug-resistant bacterial infections and preventable infectious diseases of the microbiome. Its product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains.

Contact Information

Website: www.armatapharma.com
Email: ir@armatapharma.com
Main Phone: +1 858 829-0829
Address: 4503 Glencoe Avenue
Address 2: Suite 100
State: CA
City / Town: Marina del Rey
Country: US
Postal Code: 90292

Issuer Information

Exchange: AMX
CEO: Todd R. Patrick
Employees: 38
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

$ 3.02 $ -0.189 (-5.89%)
Last Price 3.02 Change $ -0.189 Change % -5.89 Tick N/A
Bid 3.02 Bid Size 100.00 Ask 3.11 Ask Size 100.00
Open 3.21 High 3.21 Low 3.02 Prev Close 3.21
Last Trade Volume 2,133 52 Wk Hi 6.93 52 Wk Low 2.52
Market Cap 56.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 18,668,883.00 EPS (TTM) -1.92 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Jeremy L. Curnock Cook 1,000
Louis C. Drapeau 1,000
M. Scott Salka 1,000
Wendy Johnson 1,000
Last 10 Sell Shares
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 35.01 49.02 3.5 35.01
Low Target Price Estimate 7 35.01 2.5 7
Mean Target Price Estimate 21.01 42.02 3 21.01
Standard Deviation 19.81 9.9 0.71 19.81
Date of Most Recent Estimate 05/23/19 01/15/19 01/15/19 05/23/19
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1